This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition.
Iacobellis A, Ippolito A, Andriulli A.
"Casa Sollievo della Sofferenza" Hospital, IRCCS, viale Cappuccini 1, San Giovanni Rotondo 71013, Italy.
The main goals of treating cirrhotic patients with antiviral therapy are to attain sustained viral clearance (SVR), halt disease progression, and prevent re-infection of the liver graft. However, while the medical need is great, the use of interferon and ribavirin might expose these patients to severe treated-related side effects as a large proportion of them have pre-existing hematological cytopenias. We have reviewed potential benefits and risks associated with antiviral drugs in patients with liver cirrhosis, due to hepatitis C virus (HCV) infection. In cases presenting with bridging fibrosis or cirrhosis, current regimens of antiviral therapy have attained a 44%-48% rate of SVR. In cirrhotic patients with portal hypertension, the SVR rate was 22% overall, 12.5% in patients with genotype 1, and 66.7% in those with genotypes 2 and 3 following therapy with low doses of either Peg-IFN alpha-2b and of ribavirin. In patients with decompensated cirrhosis, full dosages of Peg-IFN alpha-2b and of ribavirin produced a SVR rate of 35% overall, 16% in patients with genotype 1 and 4, and 59% in those with genotype 2 and 3. Use of hematological cytokines will either ensure full course of treatment to be accomplished with and prevent development of treatment-associated side effects. Major benefits after HCV eradication were partial recovery of liver metabolic activity, prevention of hepatitis C recurrence after transplantation, and removal of some patients from the waiting list for liver transplant. Several observations highlighted that therapy is inadvisable for individuals with poor hepatic reserve (Child-Pugh-Turcotte score >= 10). Although SVR rates are low in decompensated cirrhotics due to hepatitis C, these patients have the most to gain as successful antiviral therapy is potentially lifesaving.
PMID: 19030197 [PubMed - indexed for MEDLINE
I don't see the downside to "giving it a go". At least, that was my logic. True, you may be one of the unlucky ones who has an adverse reaction to interferon, but any treatment for any illness, can be like that.
Whatever you do, good luck.
That is definitely a better option than doing nothing - that practice hasn't gotten you anywhere good at all. I wish they had advised you to try earlier.
Good luck.
That's a question we'd all like answered when contemplating tx. I also have cirrhosis (1a) and am 14 weeks into tx that was tailored for my personal issues. So far it's working..I had a complete EVR at 12 weeks with the higher dosing.
One of the most encouraging things for me, is that if I SVR, even with a cirrhotic liver, indications are that the damage CAN regress...and that's something I'm willing to fight for.
http://natap.org/2008/EASL/EASL_75.htm
For me, a Stage 4 with Grade 3 inflammation, my non-treating options ran out and I began to look harder at the percentages that DO clear, as opposed to those that don't.
And I'm not getting any younger plus being infected for 35 plus years.
It does all come down to some serious soul searching, doesn't it?
Good luck finding a decision that's right for you......Pam
Number one is to remove as many stressors on the liver as possible. NO alcohol, no NSAIDs, nothing unnatural that the liver has to filter out. Cells have been highjacked by the virus, so they scar over instead of doing their job correctly.
There are 2 new proterase inhibitors (boceprevir and teleprevir) that will hit the public market in the next 2 years. They are as rough on the blood as the standard drugs but can be monitored well by a decent doctor. They greatly increase the chances of success.
It comes down to the virus being the last stressor, so if it can be cleared with the triple drug therapy, and you don't go back to adding the other stressors like alcohol, the damage can actually reverse. Of our internal organs only the liver can repair itself. Regressing 2 stages (from 4 to 2, say) after successful treatment is not uncommon and people have even done much better than that.
It takes a year after eradication of the virus for the scarring to break down. I will get another biopsy (by choice) a year after I finish treatment and then should feel confident enough to move on with my life.
Even if you don't succeed in clearing the virus, treatment can repair enough cells to give you more time and put more distance between you and decompensated cirrhosis. Quality of life is only an issue if you believe that you will die. Keep trying. Don't give up.